Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 27, 2023.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Kevin Kavanagh, MD, examines the current bird flu outbreak and the possible dangers it holds for humans.
Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.
Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.
Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in COVID-19, a CDC shake-up, and the bird flu.
EzriCare Artificial Tears have been linked to a multistate cluster of VIM‐GES‐CRPA associated with multiple different types of infections, including eye infections, permanent vision loss, hospitalizations, and 1 death.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.